|
시장보고서
상품코드
1494468
북미의 의약품 판매 수탁 기관 시장 예측(2030년) : 지역별 분석 - 서비스, 모듈, 치료 분야, 최종사용자별North America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User |
||||||
북미의 의약품 판매 수탁 기관 시장은 2022년 39억 8,729만 달러에서 2030년에는 76억 1,412만 달러로 성장할 것으로 예측되고 있습니다. 2022-2030년의 CAGR은 8.4%를 기록할 것으로 추정됩니다.
디지털 기술의 통합이 북미의 의약품 판매 수탁 기관 시장을 촉진
디지털 기술의 도입이 가속화되면서 의약품 판매대행(CSO) 시장의 변화가 가속화되고 있습니다. 이러한 근본적인 변화는 역동적으로 변화하는 제약 시장에 대한 전술적 대응의 필요성을 강조하고 있습니다. 영업을 간소화하고, 생산성을 높이고, 디지털화된 헬스케어 환경의 복잡성을 극복하기 위해 CSO에 디지털 툴와 기술을 통합하는 것은 필수적인 요소입니다. 첨단 고객 관계 관리 툴, 인공지능 및 데이터 분석을 통해 CSO는 귀중한 인사이트을 얻고, 영업 전략을 맞춤화하며, 헬스케어 전문가와 더 깊은 관계를 구축할 수 있습니다. 정보 전달 속도를 높이고 디지털 플랫폼의 원활한 통합을 통해 시장 동향과 법률 개정에 실시간으로 대응할 수 있습니다. 제약사 CSO의 상황에서 이러한 기술적 변화는 단순한 유행에 그치지 않고 영업 전술의 개발 및 실행 방식의 근본적인 재정의에 해당합니다. 디지털 기술 채택은 CSO를 혁신의 최전선에 배치합니다. 디지털 기술 채택은 CSO를 혁신의 최전선에 배치하고, 헬스케어 산업을 휩쓸고 있는 대규모 디지털 혁신에 따라 보다 반응성이 높은 환경을 촉진합니다. 제약사 CSO는 기술적 전문성, 전략적 민첩성, 제약 생태계의 현대적 요구사항에 대한 명확한 인식이 결합된 디지털화의 힘을 계속 활용할 수 있으므로 시장은 지속적인 성장을 이룰 수 있는 위치에 있습니다.
북미 의약품 판매 수탁기관 시장 개요
북미 의약품 판매 대행 시장은 미국, 캐나다, 멕시코로 구분되며, 2022년에는 미국이 이 지역에서 가장 큰 시장 점유율을 차지할 것으로 예상되며, 예측 기간 중에도 그 우위가 지속될 것으로 예상됩니다. 북미 의약품 판매 대행 시장은 판매 대행 기업의 신기술 도입, 저분자 의약품 및 바이오 의약품 판매 촉진에 대한 제약 기업의 관심 증가, 사내 판매 업무에서 발생하는 비용 절감에 대한 관심 증가가 북미 의약품 판매 대행 시장의 성장을 가속하는 주요 요인으로 작용할 것으로 예상됩니다, 성장이 예상됩니다. IQVIA의 R&D 동향 보고서에 따르면 2021년에는 전 세계에서 84개의 새로운 활성 화합물이 출시될 것으로 예상되며, 이는 지난 5년간의 2배에 달하는 수치입니다. 국제 의약품 출시가 증가함에 따라 판매 위탁 서비스 수요도 증가할 것으로 예상됩니다. 북미가 가장 큰 시장 점유율을 차지하고 있으며, EPS Corp., IQVIA, Inc. 및 Axxelus와 같은 주요 기업이 이 지역 시장을 주도하고 있습니다.
북미 의약품 판매 수탁기관 시장 매출 및 2030년까지의 예측(금액)
북미 의약품 판매 수탁기관 시장 세분화
북미 의약품 판매 위탁기관 시장은 서비스, 모듈, 치료 분야, 최종사용자, 국가로 구분됩니다.
서비스별로 보면 북미 의약품 판매 위탁기관 시장은 상업적 서비스와 비상업적 서비스로 나뉘며, 2022년 북미 의약품 판매 위탁기관 시장에서 상업적 서비스 분야가 큰 비중을 차지할 것으로 예상됩니다.
모듈을 기준으로 북미 의약품 판매 위탁 기관 시장은 신디케이트 모듈과 전용 모듈로 나뉘며, 2022년 북미 의약품 판매 위탁 기관 시장에서 신디케이트 모듈 분야가 큰 점유율을 차지할 것으로 예상됩니다.
북미 의약품 판매 위탁 시장은 치료 분야별로 심혈관 질환, 종양, 대사성 질환, 신경, 정형외과 질환, 감염성 질환, 기타로 구분되며, 2022년 북미 의약품 판매 위탁 기관 시장에서 암 분야가 가장 큰 점유율을 차지할 것으로 예상됩니다.
최종사용자별로 보면 북미 의약품 판매 위탁기관 시장은 바이오 제약사와 제약회사로 양분됩니다. 제약사 부문은 2022년 북미 의약품 판매 대행 시장에서 더 큰 비중을 차지할 것으로 예상됩니다.
국가별로는 북미 의약품 판매 위탁 시장은 미국, 캐나다, 멕시코로 구분되며, 2022년 북미 의약품 판매 위탁 기관 시장은 미국이 지배적이었습니다.
Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, Syneos Health Inc는 북미의 의약품 판매 계약시장에서 사업을 운영하고 있는 대기업입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 북미의 의약품 판매 수탁 기관 시장 구도
- PEST 분석
- 북미 PEST 분석
제5장 북미의 의약품 판매 수탁 기관 시장 : 주요 산업 역학
- 시장 촉진요인
- 디지털 기술의 통합 진전
- 제약회사의 제품 판매 확대에 대한 관심의 증가
- 주요 시장 억제요인
- 아웃소싱에 수반하는 품질 문제
- 주요 시장 기회
- 원격의료와 원격 명세서 작성의 이용 증가
- 향후 주요 동향
- 신흥 시장에서의 확대
- 영향 분석
제6장 의약품 판매 수탁 기관 시장 : 북미 시장 분석
- 북미의 의약품 판매 수탁 기관 시장 매출, 2022-2030년
제7장 북미의 의약품 판매 수탁 기관 시장 : 2030년까지의 매출과 예측 : 서비스별
- 상업 서비스
- 비상용 서비스
제8장 북미의 의약품 판매 수탁 기관 시장 : 2030년까지의 매출과 예측 : 모듈별
- 신디케이트 모듈
- 전용 모듈
제9장 북미의 의약품 판매 수탁 기관 시장 : 2030년까지의 매출과 예측 : 치료 영역별
- 심혈관질환
- 암영역
- 대사질환
- 신경학
- 정형외과 질환
- 감염증
- 기타
제10장 북미의 의약품 판매 수탁 기관 시장 : 2030년까지의 매출과 예측 : 최종사용자별
- 바이오의약품 기업
- 제약회사
제11장 북미의 의약품 판매 수탁 기관 시장 : 국가별 분석
- 북미
- 미국
- 캐나다
- 멕시코
제12장 의약품 판매 수탁 기관 시장 : 업계 상황
- 성장 전략
제13장 기업 개요
- CMIC Holdings Co Ltd
- Axxelus Inc
- IQVIA Holdings Inc
- Peak Pharma Solutions Inc
- QFR Solutions LLC
- Promoveo Health LLC
- Syneos Health Inc
- Aenova Holding GmbH
- Pfizer Inc
- Sales Focus Inc
제14장 부록
KSA 24.06.24The North America pharmaceutical contract sales organizations market is expected to grow from US$ 3,987.29 million in 2022 to US$ 7,614.12 million by 2030. It is estimated to record a CAGR of 8.4% from 2022 to 2030.
Increasing Integration of Digital Technologies Drives North America Pharmaceutical Contract Sales Organizations Market
The increased deployment of digital technologies fuels a transformational surge in the pharmaceutical contract sales organization (CSO) market. This fundamental change highlights the need for a tactical response to the dynamically changing pharmaceutical market. An essential component of streamlining sales operations, increasing productivity, and navigating the complexities of a healthcare environment that is becoming increasingly digitized is integrating digital tools and technologies into CSOs. With advanced customer relationship management tools, artificial intelligence, and data analytics, CSOs can gain valuable insights, customize their sales strategies, and establish deeper relationships with healthcare professionals. In addition to speeding up information transmission, the seamless integration of digital platforms allows for real-time adaptability to market trends and legislative changes. This technological change in the pharmaceutical CSO landscape represents more than just a fad; it represents a fundamental redefining of how sales tactics are developed and implemented. The adoption of digital technologies places CSOs at the forefront of innovation. It promotes a more responsive environment that aligns with the larger digital transformation sweeping the healthcare sector. The market is positioned for sustained growth as pharmaceutical CSOs continue to use the power of digitalization, propelled by a convergence of technological expertise, strategic agility, and a clear awareness of the contemporary demands of the pharmaceutical ecosystem.
North America Pharmaceutical Contract Sales Organizations Market Overview
The pharmaceutical contract sales organizations market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The pharmaceutical contract sales organizations market in North America is expected to grow due to the adoption of new technologies by contract sales organizations, the surging emphasis of pharmaceutical companies in boosting the sales of small-molecule and biopharmaceutical drugs, and an increase in focus on cutting down the costs incurred by in-house sales operations are the major factors driving the growth of the pharmaceutical contract sales organizations market in North America. The number of launches of new medicine has spiked over time. According to a report by IQVIA on R&D trends, 84 new active compounds were introduced globally in 2021, twice as many as introduced in the previous 5 years. The demand for contract sales services is anticipated to rise with the increase in drug releases internationally. North America accounts for the largest share of the pharmaceutical contract sales organization market. Key players such as EPS Corp.; IQVIA, Inc.; and Axxelus fuel the market in this region.
North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)
North America Pharmaceutical Contract Sales Organizations Market Segmentation
The North America pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.
Based on services, the North America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.
Based on modules, the North America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.
Based on therapeutic area, the North America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the North America pharmaceutical contract sales organizations market in 2022.
Based on end user, the North America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.
Based on country, the North America pharmaceutical contract sales organizations market is segmented into the US, Canada, and Mexico. The US dominated the North America pharmaceutical contract sales organizations market in 2022.
Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, and Syneos Health Inc are some of the leading companies operating in the North America pharmaceutical contract sales organizations market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Pharmaceutical Contract Sales Organizations Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Increasing Integration of Digital Technologies
- 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
- 5.2 Key Market Restraints
- 5.2.1 Quality Issues Associated with Outsourcing
- 5.3 Key Market Opportunities
- 5.3.1 Rising Use of Telemedicine and Remote Detailing
- 5.4 Key Future Trends
- 5.4.1 Expansion in Emerging Markets
- 5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis
- 6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
- 7.1 Overview
- 7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
- 7.3 Commercial Services
- 7.3.1 Overview
- 7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Non-Commercial Services
- 7.4.1 Overview
- 7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
- 8.1 Overview
- 8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
- 8.3 Syndicated Modules
- 8.3.1 Overview
- 8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Dedicated Modules
- 8.4.1 Overview
- 8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
- 9.1 Overview
- 9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
- 9.3 Cardiovascular Disorders
- 9.3.1 Overview
- 9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Oncology
- 9.4.1 Overview
- 9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Metabolic Disorders
- 9.5.1 Overview
- 9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Neurology
- 9.6.1 Overview
- 9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 9.7 Orthopaedic Diseases
- 9.7.1 Overview
- 9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 9.8 Infectious Diseases
- 9.8.1 Overview
- 9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
- 10.1 Overview
- 10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
- 10.3 Biopharmaceutical Companies
- 10.3.1 Overview
- 10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Pharmaceutical Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis
- 11.1 North America
- 11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country
- 11.1.1.2 US
- 11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
- 11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
- 11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
- 11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
- 11.1.1.3 Canada
- 11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
- 11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
- 11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
- 11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
- 11.1.1.4 Mexico
- 11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
- 11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
- 11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
- 11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies
- 12.2.1 Overview
13. Company Profiles
- 13.1 CMIC Holdings Co Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Axxelus Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 IQVIA Holdings Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Peak Pharma Solutions Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 QFR Solutions LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Promoveo Health LLC
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Syneos Health Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Aenova Holding GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Pfizer Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Sales Focus Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
